GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
This Quarter Return
+11.02%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$877M
AUM Growth
+$877M
(-9.3%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-29.12%
Top 10 Holdings %
Top 10 Hldgs %
31.62%
Holding
181
New
51
Increased
7
Reduced
27
Closed
66
Top Buys
| 1 |
Nasdaq
NDAQ
|
$34.7M |
| 2 |
AB InBev
BUD
|
$30.4M |
| 3 |
Matador Resources
MTDR
|
$30M |
| 4 |
Haleon
HLN
|
$25.5M |
| 5 |
TD Synnex
SNX
|
$25.4M |
Top Sells
| 1 |
Arm
ARM
|
$119M |
| 2 |
Corebridge Financial
CRBG
|
$86.2M |
| 3 |
Las Vegas Sands
LVS
|
$73.8M |
| 4 |
GE HealthCare
GEHC
|
$31.8M |
| 5 |
PG&E
PCG
|
$27M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Financials | 15.56% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Energy | 9.79% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Atlas Energy Solutions
AESI
$1.35B
| $2.26M | 0.26% |
100,000
-90,000
| -47% | -$2.04M |
|
77
Atmus Filtration Technologies
ATMU
$3.67B
| $2.26M | 0.26% |
70,000
-50,000
| -42% | -$1.61M |
|
78
Hamilton Insurance Group
HG
$2.42B
| $2.09M | 0.24% |
150,000
-100,000
| -40% | -$1.39M |
|
79
BridgeBio Pharma
BBIO
$9.91B
| $2.09M | 0.24% |
+67,500
| New | +$2.09M |
|
80
Vesta Real Estate
VTMX
$2.33B
| $1.96M | 0.22% |
50,000
-50,000
| -50% | -$1.96M |
|
81
Atour Lifestyle Holdings
ATAT
$5.39B
| $1.79M | 0.2% |
100,000
-535,000
| -84% | -$9.6M |
|
82
MediaAlpha
MAX
$613M
| $1.56M | 0.18% |
+76,736
| New | +$1.56M |
|
83
Arhaus
ARHS
$1.57B
| $1.54M | 0.18% |
100,000
-300,000
| -75% | -$4.62M |
|
84
Ichor Holdings
ICHR
$552M
| $1.46M | 0.17% |
+37,885
| New | +$1.46M |
|
85
Inter&Co
INTR
$3.72B
| $1.43M | 0.16% |
+250,000
| New | +$1.43M |
|
86
Alphatec Holdings
ATEC
$2.35B
| $1.38M | 0.16% |
100,000
| – | – |
|
87
Metagenomi
MGX
$67.2M
| $1.32M | 0.15% |
+125,000
| New | +$1.32M |
|
88
CG Oncology
CGON
$2.19B
| $1.1M | 0.13% |
+25,000
| New | +$1.1M |
|
89
Kyverna Therapeutics
KYTX
$161M
| $994K | 0.11% |
+40,000
| New | +$994K |
|
|
NTST
90
NETSTREIT Corp
NTST
$1.69B
| $919K | 0.1% |
+50,000
| New | +$919K |
|
91
ArriVent BioPharma
AVBP
$781M
| $893K | 0.1% |
+50,000
| New | +$893K |
|
92
Klaviyo
KVYO
$9.37B
| $892K | 0.1% |
35,000
| – | – |
|
93
Bowman Consulting
BWMN
$715M
| $870K | 0.1% |
+25,000
| New | +$870K |
|
94
Perella Weinberg Partners
PWP
$1.33B
| $707K | 0.08% |
+50,000
| New | +$707K |
|
95
Fidelis Insurance
FIHL
$1.82B
| $684K | 0.08% |
35,125
| – | – |
|
96
Stoke Therapeutics
STOK
$1.08B
| $405K | 0.05% |
+30,000
| New | +$405K |
|
|
LSEA
97
DELISTED
Landsea Homes
LSEA
| $363K | 0.04% |
+25,000
| New | +$363K |
|
|
SLRN
98
DELISTED
ACELYRIN
SLRN
| $236K | 0.03% |
35,000
-35,000
| -50% | -$236K |
|
|
AUGX
99
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $102K | 0.01% |
25,000
| – | – |
|
100
Planet Labs
PL
$1.95B
| $102K | 0.01% |
40,000
| – | – |
|